GUO Xiaoyan. Expression and significance of serum immune-related factors in patients with colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 60-64. DOI: 10.7619/jcmp.201917017
Citation: GUO Xiaoyan. Expression and significance of serum immune-related factors in patients with colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 60-64. DOI: 10.7619/jcmp.201917017

Expression and significance of serum immune-related factors in patients with colorectal cancer

More Information
  • Received Date: July 16, 2019
  • Accepted Date: August 25, 2019
  • Available Online: February 28, 2021
  • Published Date: September 14, 2019
  •   Objective  To explore the expression levels and significance of peripheral blood natural killer cells (NK), CD3+, CD4+, CD8+, CD8+CD28- and the immune related factors such as tumor necrosis factor-α (TNF-α), interleukin (IL)-2, interferon-γ (IFN-γ), IL-22, IL-8 in patients with colorectal cancer (CRC).
      Methods  Totally 80 CRC patients, 54 patients with chronic enteritis and 36 healthy volunteers were selected as intestinal cancer group, benign group and healthy group. Serum levels of TNF-α, IL-2, IFN-γ, IL-22, IL-8 and peripheral blood NK, CD3+, CD4+, CD8+, CD8+CD28- were detected in all the groups. One-way ANOVA method was used to analyze the immune-related indexes. At the same time, the non-parametric Kruskal Wallis rank sum test was used to analyze the correlation between the expression of immune-related factors and pathological time in CRC patients.
      Results  There were significant differences in peripheral blood NK, CD3+, CD4+, CD8+, CD8+CD28- levels and serum TNF-α, IL-2, IFN-γ, IL-22, IL-8 among the three groups (P < 0.05). Compared with the healthy group, the peripheral blood CD8+, CD8+CD28- contents and serum TNF-α, IL-22, IL-8 levels significantly increased in the benign group and the intestinal cancer group, while the peripheral blood NK, CD3+, CD4+ and serum IL-2, IFN-γ levels significantly decreased (P < 0.05). Compared with benign group, the TNF-α, IL-22, IL-8 levels and peripheral blood CD8+, CD8+CD28ˉ contents increased significantly in the intestinal cancer group, while serum IL-2, IFN-γ levels and peripheral blood NK, CD3+, CD4+ levels significantly decreased (P < 0.05). There were significant differences in serum TNF-α, IL-2, IFN-γ, IL-22, IL-8 and peripheral blood NK, CD3+, CD4+, CD8+ and CD8+CD28- levels in patients with different clinical stages of CRC (P < 0.05). From stage Ⅰ to Ⅳ of TNM, serum TNF-α, IL-22, IL-8 levels and peripheral blood CD8+, CD8+CD28- levels significantly increased, while IL-2, IFN-γ levels and the contents of NK, CD3+ and CD4+ significantly reduced (P < 0.05).
      Conclusion  The immune-related factors such as TNF-α, IL-2, IFN-γ, IL-22, IL-8 and peripheral blood immune cells play important roles in the development of CRC, which can be used as important factors to reflect the progress of CRC and evaluate the clinical therapeutic effect of patients.
  • [1]
    徐红, 王秦. 2015-2016年度南通市城市居民癌症风险评估和筛查结果分析[J]. 现代预防医学, 2017, 44(20): 3724-3726, 3752. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201720019.htm
    [2]
    丘嘉煌, 李燕, 李科, 等. 广州市2004—2013年结直肠癌发病趋势分析[J]. 广东医学, 2016, 37(22): 3334-3337. doi: 10.3969/j.issn.1001-9448.2016.22.005
    [3]
    昌盛, 白亚娜, 蒲宏全, 等. 金昌队列人群结直肠癌疾病负担分析[J]. 中华流行病学杂志, 2016, 37(3): 325-328. doi: 10.3760/cma.j.issn.0254-6450.2016.03.006
    [4]
    冯雅靖, 王宁, 方利文, 等. 1990年与2013年中国人群结直肠癌疾病负担分析[J]. 中华流行病学杂志, 2016, 37(6): 752-757. doi: 10.3760/cma.j.issn.0254-6450.2016.06.002
    [5]
    朱文侠, 杨玲, 成钧, 等. miR-142-3p在结直肠癌组织与细胞中的表达及对细胞增殖影响研究[J]. 陕西医学杂志, 2018, 47(3): 282-286. doi: 10.3969/j.issn.1000-7377.2018.03.003
    [6]
    陆诗媛, 严婷婷, 郭方方, 等. 白介素-22与具核梭杆菌在结直肠癌发生发展中的协同作用[J]. 中国科学: 生命科学, 2018, 48(6): 684-691. https://www.cnki.com.cn/Article/CJFDTOTAL-JCXK201806008.htm
    [7]
    张泽信, 侯立朝. 程序性细胞死亡因子4在肿瘤及炎症中的交叉作用研究进展[J]. 陕西医学杂志, 2014, 43(7): 918-919. doi: 10.3969/j.issn.1000-7377.2014.07.073
    [8]
    邱海波, 伍小军, 周志伟, 等. 结直肠癌患者外周血T淋巴细胞亚群和NK细胞数目的变化及其临床意义[J]. 广东医学, 2009, 30(3): 447-449. doi: 10.3969/j.issn.1001-9448.2009.03.055
    [9]
    张泉, 邱思芳, 赵逵, 等. 结直肠癌及腺瘤患者CD4+、CD8+和CD28+ T淋巴细胞的亚群变化及临床意义[J]. 中国癌症杂志, 2018, 28(8): 577-583. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ201808004.htm
    [10]
    严健, 原永明, 张舒, 等. CD3+、CD4+、CD8+ T淋巴细胞亚群在肿瘤患者外周血中检测的临床意义[J]. 检验医学, 2013, 28(10): 901-903. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYY201310011.htm
    [11]
    吴佳茗, 陈卫昌, 张光波, 等. 结直肠癌中CD3阳性T细胞表面程序性死亡因子-1的表达及其临床意义[J]. 中华消化杂志, 2017, 37(2): 94-100. doi: 10.3760/cma.j.issn.0254-1432.2017.02.005
    [12]
    袁龙, 黄涛, 徐本玲, 等. 程序性死亡分子-1+T细胞免疫球蛋白黏蛋白结构域相关分子-3+细胞在结直肠癌患者外周血及组织CD4+ T淋巴细胞中的比例及临床意义[J]. 中华实验外科杂志, 2017, 34(5): 856-859. doi: 10.3760/cma.j.issn.1001-9030.2017.05.042
    [13]
    李绪彤, 徐丛聪, 柴洁, 等. TLR4通路相关炎症因子在结直肠癌中表达及意义[J]. 青岛大学医学院学报, 2017, 53(5): 580-582, 586. https://www.cnki.com.cn/Article/CJFDTOTAL-BATE201705025.htm
    [14]
    文坤明, 曾庆良, 冯国丽, 等. 结直肠癌患者淋巴结微转移与外周血NK细胞活性、IL-2、IL-12水平的关系[J]. 山东医药, 2011, 51(14): 16-17. doi: 10.3969/j.issn.1002-266X.2011.14.010
    [15]
    范义湘, 石卫民, 黄凯龄, 等. 干扰素-γ上调结直肠癌细胞系CEA表达的实验研究[J]. 现代消化及介入诊疗, 2010, 15(2): 78-81. doi: 10.3969/j.issn.1672-2159.2010.02.005
    [16]
    李树斌, 苏冬梅. 结肠癌患者外周血Th17和Th22细胞分布及IL-17A和IL-22的作用研究[J]. 胃肠病学和肝病学杂志, 2017, 26(8): 882-885. doi: 10.3969/j.issn.1006-5709.2017.08.011
    [17]
    Jiang R Q, Wang H Y, Deng L, et al. IL-22 is related to development of human colon cancer by activation of STAT3[J]. BMC Cancer, 2013, 13(1): 59-59. doi: 10.1186/1471-2407-13-59
    [18]
    宁珏, 叶华, 朱宇珍, 等. IL-22介导通路在结肠癌发病机制中作用的研究进展[J]. 山东医药, 2017, 57(9): 97-99. doi: 10.3969/j.issn.1002-266X.2017.09.034
  • Related Articles

    [1]WANG Zhenglin, TANG Jie, CHEN Jiawei, LIU Zixiang, ZHOU Shaobo. The role and significance of tumor necrosis factor-α in malignant tumor[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 138-143. DOI: 10.7619/jcmp.20223338
    [2]SHA Rula, QIN Ruihai, WANG Yiwei, Dahurabayila. Efficacy and molecular mechanism of cell necrosis inhibitor TAK-632 in treatment of acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 120-123. DOI: 10.7619/jcmp.20213135
    [3]TANG Yongzhi, HAO Jun, WANG Jia, ZENG Xiantie. Research status of diagnosis and treatment of adult scaphoid necrosis of foot[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 146-148. DOI: 10.7619/jcmp.20213804
    [4]HU Shanwen, WANG Lei, HOU Xiaoli, WANG Jigui, LUO Xinhui. CT versus MRI in diagnosis of early avascular necrosis of femoral head[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 40-43. DOI: 10.7619/jcmp.201907011
    [5]HU Zhichao, HUANG Sijian. Surgical treatment of 50 acute pancreatitis patients with pancreatic necrosis and pseudocyst formation[J]. Journal of Clinical Medicine in Practice, 2017, (17): 96-98. DOI: 10.7619/jcmp.201717028
    [6]HUANG Huairong, HU Fanrong. Correlation between macrophage inflammation protein-1α as well as tumor necrosis factor-α in gingival sulcus fluid and the condition of chronic periodontitis and its therapeutic efficacy[J]. Journal of Clinical Medicine in Practice, 2017, (17): 42-44. DOI: 10.7619/jcmp.201717012
    [7]XU Daxing, LI Sen, LI Yanjie, CHEN Linlin, WU Hao. Changes and significance of lactate dehydrogenase, adenosine deaminase and tumor necrosis factor-α in cerebrospinal fluid of patients with viral meningitis[J]. Journal of Clinical Medicine in Practice, 2016, (24): 26-28. DOI: 10.7619/jcmp.201624007
    [8]ZHANG Hu, LI Zhi. Effect of Astragalus injection on serum tumor necrosis factor-α, interleukin-6 and angiotensin Ⅱ in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (23): 17-19. DOI: 10.7619/jcmp.201423006
    [9]YAO Chaoqiong. Curative effect of type Ⅱ human recombinant of tumor necrosis factor receptor antibody fusion protein in the treatment of rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2013, (16): 12-14. DOI: 10.7619/jcmp.201316005
    [10]SHI Yanjun. Risk factors of systemic lupus erythematosus patients with aseptic necrosis of the femoral head[J]. Journal of Clinical Medicine in Practice, 2013, (15): 108-109. DOI: 10.7619/jcmp.201315040
  • Cited by

    Periodical cited type(2)

    1. 刘明,张国平,李德炯,李仕广,贾晓峰. 探讨磁共振“柔脑膜静脉增多扩张征”对非典型脑膜瘤的诊断价值. 贵州医药. 2023(03): 452-454 .
    2. 冷银萍. CT及多模态MRI在非典型脑膜瘤诊断中的价值分析. 影像研究与医学应用. 2021(14): 63-64 .

    Other cited types(2)

Catalog

    Article views (226) PDF downloads (14) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return